Results 121 to 130 of about 8,401,904 (201)

Efficacy and safety of recombinant von Willebrand factor in on-demand treatment of children with von Willebrand disease: up to 4 years of phase 3/3b follow-up. [PDF]

Res Pract Thromb Haemost
Bergmann S, Ahuja S, Albayrak C, Cnossen MH, Dunn AL, Labarque V, Luciani M, Male C, Mullins ES, Susen S, Vera PM, Mokdad AG, Wang Y, Weng J, Zhang J.   +14 more
europepmc   +1 more source

von Willebrand Factor: An Unhealthy Bond between Lung Endothelium and Pulmonary Fibrosis. [PDF]

Am J Respir Cell Mol Biol
Chao J, Farkas L.
europepmc   +1 more source

Optical-Tweezer Single-Molecule Assay for ADAMTS13-Mediated Proteolysis of the von Willebrand Factor A2 Domain. [PDF]

Methods Mol Biol
Chen W, Cao W, Zheng XL, Zhang XF.
europepmc   +1 more source

RUNX1 promotes pathological retinal angiogenesis through von Willebrand factor. [PDF]

Adv Ophthalmol Pract Res
Liu Y, He C, Luo X, Sui A, He J, Zhang Y, Wu D.   +6 more
europepmc   +1 more source

Retrospective analysis of von willebrand factor and microthrombus formation in septic shock: associations with TTP-like syndrome and sepsis-induced coagulopathy. [PDF]

Am J Clin Exp Immunol
Liu Y, Yue J, Huang Q, Wan L, Zhao W, Ren Z, Han C, Zhang B, Li C, Pan L, Zhang H, Zhang J.   +11 more
europepmc   +1 more source

ADAMTS-13 R1206K variant exhibits an open conformation and an enhanced proteolytic activity toward von Willebrand factor. [PDF]

J Thromb Haemost
Liu S, Dong X, Bonnez Q, Chai Z, Meng C, Gil M, Vanhoorelbeke K, Halkidis K, Zheng XL.   +8 more
europepmc   +1 more source

Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease. [PDF]

Blood Adv
Daniel MY, Rauch A, Paris C, Jeanpierre E, Goudemand J, Marichez C, Pradines B, Zawadzki C, Dupont A, Denis CV, Lenting PJ, Susen S, Delavenne X.   +12 more
europepmc   +1 more source

Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain. [PDF]

PLoS Comput Biol
Sacco M, Lancellotti S, Ferretti A, Basso M, Di Gennaro L, Castaman G, De Cristofaro R.   +6 more
europepmc   +1 more source

Von Willebrand factor medates distinct mechanisms of vegetation formation in streptococcus mutans-induced endocarditis: comparisons between damage-induced and inflammation-induced mouse models. [PDF]

Front Cardiovasc Med
Li A, Qian J, Zhou K, Yuan Y, Ma S, Zhang D, Jiang X, Chen M.   +7 more
europepmc   +1 more source

Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders. [PDF]

Thromb Haemost
Jongejan YK, van Vlijmen BJM, Eikenboom JCJ.   +2 more
europepmc   +1 more source